Similarly, it has also been reported in a 51-year-old woman with triple-negative breast cancer with a history of modified radical mastectomy after she received chemotherapy combined with PD-1 inhibitors [10]. The gene discussed is PDCD1; the disease is triple-negative breast carcinoma.